Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Paul R. Vigano, a ten percent owner of Aveanna Healthcare Holdings , Inc. (NASDAQ:AVAH), recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Vigano sold 750,000 shares of Aveanna Healthcare’s common stock on June 10, 2025, at a price of $5.20 per share, totaling $3.9 million. The transaction comes as the company’s stock has shown remarkable strength, delivering a 106% return over the past year, though InvestingPro analysis suggests the stock is currently trading slightly above its Fair Value.
Following this transaction, Vigano’s direct ownership stake in the company has been reduced to zero shares. However, he maintains indirect ownership through various entities, including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and others, with substantial shares still held across these entities.
The transaction reflects Vigano’s continued involvement with the company through indirect holdings, even as he reduces his direct stake.
In other recent news, Aveanna Healthcare Holdings Inc. reported impressive earnings for the first quarter of 2025, surpassing expectations with an earnings per share of $0.10 against a forecasted loss of $0.0014. The company’s revenue reached $559 million, exceeding the anticipated $513.7 million. Aveanna has projected its annual revenue to exceed $2.15 billion, reflecting a robust outlook for the year. Additionally, the company announced results from its 2025 Annual Meeting of Stockholders, where stockholders voted on three proposals, including the election of directors and the ratification of Ernst & Young LLP as the independent auditor.
Aveanna’s strategic growth initiatives, including acquisitions and payer agreements, are expected to enhance future performance. The company demonstrated a 14% year-over-year increase in revenue and a significant rise in adjusted EBITDA, which was up 93.1% year-over-year, reaching $67.4 million. In terms of liquidity, Aveanna reported $266 million, including $128 million in cash. The company’s ongoing efforts to improve Medicaid policy discussions and preferred payer agreements continue to be a focal point for enhancing financial outcomes.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.